Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Journal of the International AIDS Society|September 6, 2019
Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surfaceVic Arendt, Mathieu Amand, Gilles Iserentant, et al.
Neuro-Oncology Advances|July 10, 2020
The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein-protein interaction in glioblastomaVirginie Neirinckx, Ann-Christin Hau, Anne Schuster, et al.
ACS Omega|March 10, 2025
Design, Synthesis and Pharmacological Characterization of the First Photoswitchable Small-Molecule Agonist for the Atypical Chemokine Receptor 3Sophie Bérenger, Justyna M Adamska, Francesca Deflorian, et al.
Nature Communications|June 21, 2020
The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptidesMax Meyrath, Martyna Szpakowska, Julian Zeiner, et al.
Biochemical Pharmacology|August 4, 2024
Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonismStephanie M Anbuhl, Xavier Dervillez, Saskia Neubacher, et al.
Communications Biology|July 2, 2024
GRK specificity and Gβγ dependency determines the potential of a GPCR for arrestin-biased agonismEdda S F Matthees, Jenny C Filor, Natasha Jaiswal, et al.
Nature Communications|November 12, 2022
Computationally designed GPCR quaternary structures bias signaling pathway activationJustine S Paradis, Xiang Feng, Brigitte Murat, et al.
Cellular and Molecular Life Sciences : CMLS|June 24, 2026
Physical interaction with Ephrin B1 promotes CXCR4 intracellular localization and oncogenic potentialAlessandro Rabbito, Omolade Otun, Amos Fumagalli, et al.
ACS Pharmacology & Translational Science|July 18, 2024
Fluorophore-Labeled Pyrrolones Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR1Lara Toy, Max E Huber, Minhee Lee, et al.
Journal of Medicinal Chemistry|September 23, 2022
Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation ModulationAlp Bayrak, Florian Mohr, Kyra Kolb, et al.
Pageof 9